(Q43796180)

26 November 2017

title

Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone (English)

1 reference

26 November 2017

1 reference

Y Yazaki

1

1 reference

26 November 2017

M Isobe

2

1 reference

26 November 2017

M Hiroe

3

1 reference

26 November 2017

S Morimoto

4

1 reference

26 November 2017

S Hiramitsu

5

1 reference

26 November 2017

T Nakano

6

1 reference

26 November 2017

T Izumi

7

1 reference

26 November 2017

M Sekiguchi

8

1 reference

26 November 2017

Central Japan Heart Study Group

9

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

American Journal of Cardiology

26 November 2017

published in

1 reference

26 November 2017

volume

88

1 reference

26 November 2017

issue

9

1 reference

26 November 2017

page(s)

1006-1010

1 reference

26 November 2017

cites work

Myocardial sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

Cardiac sarcoidosis. Diagnosis with endomyocardial biopsy and treatment with corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

Steroid therapy in cardiac sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

Cardiac sarcoidosis; a major cause of sudden death in young individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

Natural history of idiopathic dilated cardiomyopathy: effect of referral bias and secular trend

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

Impact of left ventricular cavity size on survival in advanced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901978-6

10.1016/S0002-9149(01)01978-6

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference